Meprosin

Meprosin Brand names, Meprosin Analogs

Meprosin Brand Names Mixture

No information avaliable

Meprosin Chemical_Formula

C₂₀H₂₃NS

Meprosin RX_link

No information avaliable

Meprosin fda sheet

Meprosin msds (material safety sheet)

Meprosin Synthesis Reference

No information avaliable

Meprosin Molecular Weight

309.469 g/mol

Meprosin Melting Point

< 25 ^oC

Meprosin H₂O Solubility

Soluble as HCl salt

Meprosin State

Liquid

Meprosin LogP

5.7

Meprosin Dosage Forms

Tablets (oral, 1 mg)

Meprosin Indication

Used for the symptomatic treatment of parkinsonism.

Meprosin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprosin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprosin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprosin Patient Information

Meprosin Organisms Affected

Humans and other mammals